- Conditions
- Cardiovascular Diseases, Peripheral Vascular Disease, Arterial Occlusive Diseases, Peripheral Arterial Disease, Critical Limb Ischemia
- Interventions
- Paclitaxel administration using the OPC
- Other
- Lead sponsor
- Horizons International Peripheral Group
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 4
- States / cities
- Fairhope, Alabama • Houma, Louisiana • Dearborn, Michigan + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Peripheral Arterial Disease
- Interventions
- Ranolazine, Placebo
- Drug
- Lead sponsor
- Corewell Health East
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- Royal Oak, Michigan
- Conditions
- Intermittent Claudication
- Interventions
- Walking Exercise
- Behavioral
- Lead sponsor
- National Institute on Aging (NIA)
- NIH
- Eligibility
- 45 Years to 90 Years
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1994 – 2000
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Peripheral Artery Disease, Overweight or Obesity
- Interventions
- Weight loss, Exercise
- Behavioral
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 212 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 7
- States / cities
- Chicago, Illinois • New Orleans, Louisiana • Baltimore, Maryland + 3 more
- Conditions
- Peripheral Arterial Disease(PAD)
- Interventions
- Rotarex(TM) Rotational Excisional Atherectomy System
- Device
- Lead sponsor
- C. R. Bard
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 2
- States / cities
- Lakeland, Florida • Humble, Texas
- Conditions
- Cardiovascular Disease, Peripheral Artery Disease, Ischemic Stroke, Diabetes
- Interventions
- Web-Based Intervention
- Behavioral
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 98 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2014
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Intermittent Claudication, Arteriosclerosis
- Interventions
- DNA Plasmid Vector, EW-A-401 DNA Plasmid Vector
- Drug
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Eligibility
- 21 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2011
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • Bethesda, Maryland • Madison, Wisconsin
- Conditions
- Arterial Disease of Legs, Below-the-knee Obstruction, PAD - Peripheral Arterial Disease
- Interventions
- MagicTouch PTA Sirolimus drug coated balloon, Placebo balloon angioplasty
- Device
- Lead sponsor
- Concept Medical Inc.
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 368 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 29
- States / cities
- Scottsdale, Arizona • Los Angeles, California • Clearwater, Florida + 22 more
- Conditions
- Peripheral Arterial Disease, Peripheral Vascular Diseases, Catheterization, Peripheral
- Interventions
- NVS Therapy
- Combination Product
- Lead sponsor
- Alucent Biomedical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 3
- States / cities
- Columbus, Ohio • Wynnewood, Pennsylvania • Kingsport, Tennessee
- Conditions
- Aortic Aneurysm, Abdominal, Carotid Stenosis, Peripheral Arterial Disease
- Interventions
- Not listed
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- 55 Years and older
- Enrollment
- 190 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2021
- U.S. locations
- 1
- States / cities
- Evanston, Illinois
- Conditions
- Critical Limb Ischemia
- Interventions
- Low Dose VM202, High Dose VM202, Placebo
- Biological · Other
- Lead sponsor
- Helixmith Co., Ltd.
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2023
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Orange, California • Chicago, Illinois + 9 more
- Conditions
- Peripheral Artery Disease
- Interventions
- Diamondback 360 Extended Length Orbital Atherectomy System
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 6
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Lafayette, Louisiana + 2 more
- Conditions
- Peripheral Arterial Disease, Acute Limb Ischemia
- Interventions
- Pounce Thrombectomy System
- Device
- Lead sponsor
- SurModics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 9
- States / cities
- Peoria, Illinois • Munster, Indiana • Baton Rouge, Louisiana + 6 more
- Conditions
- Carotid Atherosclerosis, Peripheral Arterial Disease
- Interventions
- Not listed
- Lead sponsor
- Elucid Bioimaging Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 125 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 2
- States / cities
- Marrero, Louisiana • New Orleans, Louisiana
- Conditions
- Tobacco Cessation, Peripheral Artery Disease
- Interventions
- Tobacco Treatment Research Program Standard Care
- Behavioral
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Peripheral Vascular Disease
- Interventions
- Liprostin [liposomal Prostaglandin E1]
- Drug
- Lead sponsor
- Endovasc
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Peripheral Arterial Disease, Walking, Difficulty, Inflammation
- Interventions
- Calf Plantar flexion, Dietary nitrate
- Device · Dietary Supplement
- Lead sponsor
- University of Wisconsin, La Crosse
- Other
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2029
- U.S. locations
- 1
- States / cities
- La Crosse, Wisconsin
- Conditions
- Peripheral Vascular Disease
- Interventions
- VLTS-934
- Drug
- Lead sponsor
- Valentis
- Industry
- Eligibility
- 40 Years to 78 Years
- Enrollment
- 148 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Beverly Hills, California • Los Angeles, California + 29 more
- Conditions
- Peripheral Arterial Disease, Peripheral Vascular Diseases, Critical Limb Ischemia
- Interventions
- Bone marrow concentration device
- Device
- Lead sponsor
- Zimmer Biomet
- Industry
- Eligibility
- 21 Years and older
- U.S. locations
- 9
- States / cities
- Little Rock, Arkansas • Atlanta, Georgia • Indianapolis, Indiana + 5 more
- Conditions
- Peripheral Artery Disease, Arteriovenous Fistula Stenosis, Arteriovenous Graft Stenosis
- Interventions
- FLEX Vessel Prep System followed by angioplasty
- Device
- Lead sponsor
- VentureMed Group Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 114 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 10
- States / cities
- Birmingham, Alabama • Dothan, Alabama • Tuscaloosa, Alabama + 7 more
- Conditions
- Intermittent Claudication, Ischemia Vascular, Peripheral Arterial Disease, Peripheral Vascular Disease
- Interventions
- Ischemic Preconditioning, Control Group
- Other
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- Peripheral Vascular Diseases
- Interventions
- Treatment with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface
- Device
- Lead sponsor
- W.L.Gore & Associates
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 119 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2011
- U.S. locations
- 5
- States / cities
- Oceanside, California • Chicago, Illinois • Columbia, Missouri + 2 more
- Conditions
- Prediabetic State, Atherosclerosis, Metformin
- Interventions
- Metformin XR, Placebo
- Drug
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 7,410 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2029
- U.S. locations
- 40
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 37 more
- Conditions
- Diabetes Mellitus, Type 2, Peripheral Arterial Disease
- Interventions
- Semaglutide, Placebo (semaglutide)
- Drug
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 792 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 88
- States / cities
- Birmingham, Alabama • Chandler, Arizona • Glendale, Arizona + 64 more